Skip to content
Companies

Vivamed

Wireless nerve stimulation implant for sleep apnea

Raised to date

$3M

of $3M offered across 1 Form D filing

Investors
1
Last filed
May 27, 2026

About

Vivamed is a Santa Monica, California medical device company developing a minimally invasive implant that treats obstructive sleep apnea (OSA) with hypoglossal nerve stimulation. Its device is described as wireless and battery-less, removing the large surgical incisions and implanted power source that current hypoglossal nerve stimulation systems require. The company was founded in 2024 out of UCLA by CEO Sepideh Nouri and is a member of the Medical Technology Enterprise Consortium (MTEC) and a Creative Destruction Lab 2024/25 cohort company. It is pre-commercial and raising seed capital.

Wireless, battery-less hypoglossal nerve stimulation, which removes the implanted pulse generator and battery that force large incisions in existing systems - shortening surgery and recovery, widening physician adoption, and lowering the cost of the therapy to the health system.

Funding

  • EquityFiled May 27, 2026Form D
    $3M/ $3M

Product

Minimally invasive hypoglossal nerve stimulation implant

Implantable medical device

An implantable neuromodulation device that stimulates the hypoglossal nerve to keep the upper airway open during sleep, positioned by the company as 'Transforming Obstructive Sleep Apnea Treatment with Minimally Invasive Neuromodulation.'

  • Hypoglossal nerve stimulation for obstructive sleep apnea
  • Wireless operation
  • Battery-less - no implanted power source

Built for

Adults with obstructive sleep apnea who cannot tolerate CPAP, reached through the sleep surgeons and ENT specialists who implant neurostimulation devices.

People on file